Per Wändell1, Gunnar Ljunggren, Amadou Jallow, Lars Wahlström, Axel C Carlsson. 1. From the Division for Family Medicine, Department of Neurobiology, Care Sciences and Society (Wändell, Ljunggren, Carlsson), Karolinska Institutet; Academic Primary Health Care Centre (Ljunggren, Carlsson); Skala Professionals AB (Jallow); and Centre for Psychiatry Research, Karolinska Institutet (Wahlström), Stockholm, Sweden.
Abstract
OBJECTIVE: We compare individuals with newly diagnosed HIV with sex-, age-, and socioeconomic status-matched HIV-negative controls, with the aim of studying the frequency of health care visits, the types of clinics visited, registered diagnoses, and psychopharmacotherapy. METHODS: The data were collected through the Stockholm Region administrative database (Stockholm Regional Health Care Data Warehouse) for men and women (people) living with newly diagnosed HIV (PLWH) in their medical records (930 men, 450 women) and controls. The odds ratios (ORs) with 99% confidence intervals (CIs) for psychiatric comorbidities and relevant pharmacotherapies were calculated during the 2011-2018 period. RESULTS: Substance use disorder was higher in PLWH than in controls, before and after newly diagnosed HIV in men (OR = 1 year before 4.36 [99% CI = 2.00-9.5] and OR = 1 year after 5.16 [99% CI = 2.65-10.08]) and women (OR = 1 year before 6.05 [99% CI = 1.89-19.40] and OR = 1 year after 5.24 [99% CI = 1.69-16.32]). Health care contacts and psychiatric disorders were more common in cases than controls 1 and 2 years after diagnosis, particularly for depression in men 1 year after HIV (OR = 3.14, 99% CI = 2.11-4.67), which was not found in women (1 year OR = 0.94, 99% CI = 0.50-1.77). CONCLUSIONS: Before newly diagnosed HIV, PLWH have the same level of psychiatric diagnoses as their controls, except for substance use disorder. Psychiatric problems are more common in PLWH than in their controls after newly diagnosed HIV.
OBJECTIVE: We compare individuals with newly diagnosed HIV with sex-, age-, and socioeconomic status-matched HIV-negative controls, with the aim of studying the frequency of health care visits, the types of clinics visited, registered diagnoses, and psychopharmacotherapy. METHODS: The data were collected through the Stockholm Region administrative database (Stockholm Regional Health Care Data Warehouse) for men and women (people) living with newly diagnosed HIV (PLWH) in their medical records (930 men, 450 women) and controls. The odds ratios (ORs) with 99% confidence intervals (CIs) for psychiatric comorbidities and relevant pharmacotherapies were calculated during the 2011-2018 period. RESULTS: Substance use disorder was higher in PLWH than in controls, before and after newly diagnosed HIV in men (OR = 1 year before 4.36 [99% CI = 2.00-9.5] and OR = 1 year after 5.16 [99% CI = 2.65-10.08]) and women (OR = 1 year before 6.05 [99% CI = 1.89-19.40] and OR = 1 year after 5.24 [99% CI = 1.69-16.32]). Health care contacts and psychiatric disorders were more common in cases than controls 1 and 2 years after diagnosis, particularly for depression in men 1 year after HIV (OR = 3.14, 99% CI = 2.11-4.67), which was not found in women (1 year OR = 0.94, 99% CI = 0.50-1.77). CONCLUSIONS: Before newly diagnosed HIV, PLWH have the same level of psychiatric diagnoses as their controls, except for substance use disorder. Psychiatric problems are more common in PLWH than in their controls after newly diagnosed HIV.
Authors: Martin St-Jean; Hiwot Tafessu; Kalysha Closson; Thomas L Patterson; M Ruth Lavergne; Julius Elefante; Lianping Ti; Mark W Hull; Robert S Hogg; Rolando Barrios; Jean A Shoveller; Julio S G Montaner; Viviane D Lima Journal: Can J Public Health Date: 2019-08-22
Authors: Fiona Judd; Angela Komiti; Phyllis Chua; Anne Mijch; Jennifer Hoy; Paul Grech; Alan Street; John Lloyd; Ben Williams Journal: Aust N Z J Psychiatry Date: 2005-09 Impact factor: 5.744
Authors: Faith E Fletcher; Nicholas R Sherwood; Whitney S Rice; Ibrahim Yigit; Shericia N Ross; Tracey E Wilson; Sheri D Weiser; Mallory O Johnson; Mirjam-Colette Kempf; Deborah Konkle-Parker; Gina Wingood; Janet M Turan; Bulent Turan Journal: AIDS Patient Care STDS Date: 2020-08 Impact factor: 5.078
Authors: Jennifer Dykxhoorn; Joseph Hayes; Kavya Ashok; Alma Sörberg Wallin; Christina Dalman Journal: Psychol Med Date: 2021-07-07 Impact factor: 10.592
Authors: Janaíra da Silva Nascimento; Paulo Sérgio Ramos de Araújo; Valter Romão de Souza Júnior; Fábio Lopes de Melo; Daniel Sá Araújo Lins Carvalho; Vera Magalhães Journal: Medicine (Baltimore) Date: 2019-06 Impact factor: 1.817